Biopharma companies can help healthcare providers and specialist physicians stay abreast of scientific and medical information. Sej Brar describes what it takes to reshape and transform the strategic relevance of the medical affairs function. Related Practice Life Sciences & Pharma
Paper & Packaging Executive Insights Finding Growth Opportunities in a Complex Market: Healthcare Components and Solutions May 19, 2021 HCCS companies are attractive acquisition targets, generating greater margins than other sectors due to product complexity, mission criticality, high…
Healthcare Services Presentations Election 2020: The Next Phase of the US Healthcare Policy War October 19, 2020 The results of this study are reflective of news as of October 19, 2020. Overview of key policies and additional details on overall feasibility by…
Life Sciences & Pharma Article ASCO 2021 Social Listening: Major Data Readouts and Themes July 27, 2021 L.E.K. Consulting used social listening to gauge the sentiment of virtual attendees at the ASCO 2021 meeting.
Life Sciences & Pharma Published Articles How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment October 8, 2020 Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market…
Life Sciences & Pharma Executive Insights European Drug Pricing and Market Access in a COVID-19 World October 14, 2020 On 3 June 2020, Médecins Sans Frontières (MSF) issued an appeal urging world leaders to ensure that pharmaceutical companies sell any COVID-19 vaccines at…
Life Sciences & Pharma Video / Webinar How Have Hospitals Across APAC Adapted to the Impact of COVID-19? April 8, 2021 L.E.K. Consulting’s survey of hospital executives at private and public hospitals in the Asia Pacific region reveals three key themes.
